However, BChE activity could serve as a biomarker in PD patient to assess disease severity, discriminate PD-related dementia, evaluate efficacy of drugs, and instruct physicians about the course of clinical medications for dementia. The gene discussed is BCHE; the disease is Parkinson disease.